The Eyevensys Breakthrough Technology


Long-term efficacy of ciliary muscle gene transfer of three sFlt-1 variants in a rat model of laser-induced choroidal neovascularization.

El Sanharawi M, Touchard E, Benard R, Bigey P, Escriou V, Mehanna C, Naud MC, Berdugo M, Jeanny JC, Behar-Cohen F.

Gene Ther, 2013. 20(11):1093-103.

Non-viral gene therapy for GDNF production in RCS rat: the crucial role of the plasmid dose.

Touchard E, Heiduschka P, Berdugo M, Kowalczuk L, Bigey P, Chahory S, Gandolphe C, Jeanny JC, Behar-Cohen F.

Gene Ther, 2012. 19(9):886-98.

The ciliary smooth muscle electrotransfer: basic principles and potential for sustained intraocular production of therapeutic proteins.

Touchard E, Kowalczuk L, Bloquel C, Naud MC, Bigey P, Behar-Cohen F.

J Gene Med, 2010. 12(11):904-19.

Protein delivery for retinal diseases: from basic considerations to clinical applications.

El Sanharawi M, Kowalczuk L, Touchard E, Omri S, de Kozak Y, Behar-Cohen F.

Prog Retin Eye Res, 2010. 29(6):443-65. Review.

Effects of ciliary muscle plasmid electrotransfer of TNF-alpha soluble receptor variants in experimental uveitis.

Touchard E, Bloquel C, Bigey P, Kowalczuk L, Jonet L, Thillaye-Goldenberg B, Naud MC, Scherman D, de Kozak Y, Benezra D, Behar-Cohen F.

Gene Ther, 2009. 16(7):862-73.

Local ocular immunomodulation resulting from electrotransfer of plasmid encoding soluble TNF receptors in the ciliary muscle.

Kowalczuk L, Touchard E, Camelo S, Naud MC, Castaneda B, Brunel N, Besson-Lescure B, Thillaye-Goldenberg B, Bigey P, BenEzra D, de Kozak Y, Behar-Cohen F.

Invest Ophthalmol Vis Sci, 2009. 50(4):1761-8.

Electrically assisted ocular gene therapy.

Bejjani RA, Andrieu C, Bloquel C, Berdugo M, BenEzra D, Behar-Cohen F.

SurvOphthalmol, 2007. 52(2):196-208. Review.

Non-viral ocular gene therapy: potential ocular therapeutic avenues.

Bloquel C, Bourges JL, Touchard E, Berdugo M, BenEzra D, Behar-Cohen F.

Adv Drug DelivRev, 2006. 58(11):1224-42. Review.

Plasmid electrotransfer of eye ciliary muscle: principles and therapeutic efficacy using hTNF-alpha soluble receptor in uveitis.

Bloquel C, Bejjani R, Bigey P, Bedioui F, Doat M, BenEzra D, Scherman D, Behar-Cohen F.

FASEB J, 2006. 20(2):389-91.